








KISEP Rhinology Korean J Otolaryngol 2005;48:320-5 
?





Effect of Ginkgo Biloba Extract(EGb 761) on Apoptosis in Oral Cavity Cancer Cells 
?
Kwang-Hyeon Rhee, MD1, Joo-Heon Yoon, MD1,2, Joo-Hwan Lee, MD1,  
Soon Ho Kwon, MD1, Hyung Seok Seo, MD1 and Kyung-Su Kim, MD1,2 
1Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul? and  
2Brain Korea 21 Project for Medical Sciences, Seoul, Korea 
?
ABSTRACT 
Background and Objectives：To examine the chemopreventive effects of Ginkgo biloba extract (EGb 761) on oral cavity 
cancer, we investigated the apoptosis of oral cavity cancer cells by EGb 761 and the apoptotic pathway involved. Materials and 
Method：SCC 1483 cancer cell line derived from a human retromolar trigone carcinoma was used. Inhibition of proliferation 
was examined by proliferation assay. Apoptosis was measured and confirmed by flow cytometry, DNA fragmentation assay and 
Western blotting with PARP antibodies. The involvement of the caspase cascade was investigated by co-treating with the 
caspase inhibitor, z-VAD-fmk. Results：The inhibition of SCC 1483 cells was noted from 250 μg/ml of EGb 761. Apoptosis 
was observed after 24 hours of incubation with 250 μg/ml EGb 761 and it occurred in a time-dependent manner. Apoptosis was 
confirmed by DNA fragmentation and PARP cleavage. Co-treatment with z-VAD-fmk inhibited apoptosis and PARP cleavage 
by EGb 761. Conclusions：EGb 761 induces the apoptosis of SCC 1483 cells and the caspase cascade is involved in this 
apoptosis. Therefore, EGb 761 may be used as a chemopreventive agent in oral cavity cancer. Further studies are required on the 
clinical use of EGb 761. (Korean J Otolaryngol 2005;48:320-5) 
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Table 1. Inhibition of SCC 1483 cells proliferation according to 
the concentrations of EGb 761 
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Fig. 1. Inhibition of SCC 1483 cell proliferation by EGb 761. SCC
1483 cells were treated with 0, 50, 100, 200, 250, and 500 ?g/ml
EGb 761 for 48 hours and cell proliferation was determined.
Compared with control ?0 or DMSO-treated cells?, cell prolife-
ration is noted from 250 ?g/ml EGb 761 and is increased dose-
dependently. 
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Fig. 2. Time-dependent apoptosis
of SCC 1483 cells by EGb 761. SCC
1483 cells were incubated with 250
?g/ml EGb 761 for 24 and 48 hours
and flow cytometry using Annexin
V-FITC was performed. Compared
with control ?0 hour?, the apoptotic
cells of 24 hours incubation show
approximately 2.6-fold increase and
those of 48 hours incubation show
approximately 3.1-fold increase. 
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Table 2. Inhibition of apoptosis of SCC 1483 cells by co-treat-
ment of EGb 761 and z-VAD-fmk 
 Apoptosis ?%? 
Control 08.7?1.3 










Fig. 3. A. DNA fragm-
entation of SCC 1483
cells by EGb 761. SCC
1483 cells were incub-
ated with 250 ?g/ml 
EGb 761 for 24 hours.
Afterward, genomic 
DNA was extracted 
and the electrophore-
sis was done. Comp-
ared with control ???, 
genomic DNA of EGb
761-added cells ??? 
show the fragmented
ladder pattern. B?Cle-
avage of PARP by EGb
761. SCC 1483 cells
were incubated with
250 ?g/ml EGb 761 for
24 hours and the cell





rol ???, the cells tre-
ated with EGb 761 ??? 
show the cleavage of
PARP as 116 kDa and




Fig. 4. Inhibition of cleavage of PARP by z-VAD-fmk. SCC 1483
cells were incubated with 250 ?g/ml EGb 761 and were co-
incubated with 250 ?g/ml EGb 761 and 10 ?M z-VAD-fmk for
24 hours. After then, the cell lysates were made and Western
blot analysis with anti-PARP antibody was performed. Compared
with control ???, the cells treated only with EGb 761 ?EGb? show
the cleavage of PARP as 116 kDa and 89 kDa. However, the
cells treated both with EGb 761 and z-VAD-fmk ?EGb?z-VAD-
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